Parexel and ASAN accelerate Korea-based drug development

Wednesday, February 1, 2012 03:33 PM

CRO Parexel International has joined with ASAN Medical Center (AMC), based in Seoul, Korea, to offer clinical trial sponsors based regionally and internationally access to clinical trial services throughout Asia, with a focus on early phase development.

“With ASAN Medical Center's leadership in clinical trials, in-depth expertise, state-of-the art facilities and a renowned network of hospitals, we believe our alliance will offer unique advantages to the Korean biopharmaceutical industry,” said Mark A. Goldberg, M.D., COO of Parexel. “We look forward to contributing to continued drug development growth in the region through shared learnings, technologies and best practices."

The AMC Clinical Trial Center, which opened in 2002, was designated as the Regional Clinical Trial Center by the Korean Ministry for Health, Welfare and Family Affairs in 2006. The government's investment made it possible for the center to rapidly build infrastructure. 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs